This week's artwork was donated by Lonny, a pediatric cancer patient who received treatment at The Children's Hospital of Philadelphia . Standard Complete surgical removal of the tumor, with or without regional lymph node dissection. The treatment of patients who have tumors with local invasion, but without clinically enlarged regional lymph nodes, is complete surgical removal as for stage I and stage II tumors. For those with enlarged regional lymph nodes, a lymph node dissection should be included in the procedure. These patients are at high risk for disease recurrence and should be considered for enrollment in a clinical trial.
Clinical trials are appropriate for newly diagnosed patients when possible.
Responses in patients who achieve complete remission can be durable. The drug is not usually used unless either radiologically evaluable metastases are present or the residual tumor is producing measurable levels of hormone. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. PDQ statements exist for a number of topics.